xml_file stringlengths 5 11 | reference_id stringlengths 1 7 | date_last_updated stringclasses 487
values | pubmed_id stringlengths 5 8 ⌀ | article_year int64 1.95k 2.03k ⌀ | article_title stringlengths 23 347 ⌀ | journal_title stringlengths 3 197 ⌀ | authors stringlengths 5 2.35k ⌀ | epitope_id stringlengths 1 7 ⌀ | epitope_name stringlengths 1 85 ⌀ | epitope_structure_type stringclasses 8
values | epitope_chemical_type stringclasses 18
values | linear_sequence stringlengths 1 829 ⌀ | linear_sequence_length int64 1 829 ⌀ | discontinuous_residues stringlengths 2 419 ⌀ | starting_position int64 0 34.8k ⌀ | ending_position int64 3 34.8k ⌀ | source_organism_id stringlengths 1 8 ⌀ | source_molecule_genbank_id stringlengths 4 14 ⌀ | reference_region stringlengths 2 409 ⌀ | epitope_structure_defines stringclasses 4
values | epitope_evidence_code stringclasses 6
values | assay_category stringclasses 4
values | assay_id stringlengths 2 8 | assay_type_id stringclasses 412
values | assay_location_of_data stringlengths 4 126 ⌀ | qualitative_measurement stringclasses 5
values | is_positive bool 2
classes | quantitative_measurement stringlengths 3 25 ⌀ | host_organism_id stringclasses 729
values | host_sex stringclasses 2
values | host_age stringlengths 1 39 ⌀ | disease_state stringclasses 666
values | mhc_allele_id stringclasses 868
values | mhc_allele_types_present stringlengths 1 150 ⌀ | cell_type stringclasses 41
values | cell_tissue_type stringclasses 49
values | cell_culture_conditions stringclasses 9
values | antigen_evidence_code stringclasses 6
values | immunogen_evidence_code stringclasses 6
values | assay_comments stringclasses 0
values | split_bucket int64 1 9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1048174.xml | 1048174 | 2026-04-03-07:00 | 41859109 | 2,026 | Immunoreactivity of pan MHC-I epitopes on Crimean-Congo hemorrhagic fever virus glycoprotein C-terminal. | Frontiers in immunology | Dongbo Jiang; Yongkai Wang; Haobo Kang; Zhenchi Fang; Jianchang Li; Zilu Ma; Yubo Sun; Yanbo Wang; Zhihe Fu; Yulin Yang; Enqi Guan; Yuanjie Sun; Shuya Yang; Chunmei Zhang; Yusi Zhang; Yun Zhang; Baozeng Sun; Kun Yang; Linfeng Cheng | 2454109 | EPDELTVHV | FragmentOfANaturalSequenceMolecule | Peptide from protein | EPDELTVHV | 9 | null | 1,472 | 1,480 | 652961 | AAM48106.1 | null | Exact Epitope | null | TCell | 28536595 | 49 | Figure 4 | Positive-Low | true | null | 10000649 | F | 6-8 weeks | null | 137 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Representative selection | null | 8 |
1048174.xml | 1048174 | 2026-04-03-07:00 | 41859109 | 2,026 | Immunoreactivity of pan MHC-I epitopes on Crimean-Congo hemorrhagic fever virus glycoprotein C-terminal. | Frontiers in immunology | Dongbo Jiang; Yongkai Wang; Haobo Kang; Zhenchi Fang; Jianchang Li; Zilu Ma; Yubo Sun; Yanbo Wang; Zhihe Fu; Yulin Yang; Enqi Guan; Yuanjie Sun; Shuya Yang; Chunmei Zhang; Yusi Zhang; Yun Zhang; Baozeng Sun; Kun Yang; Linfeng Cheng | 2454165 | QPQSILIEH | FragmentOfANaturalSequenceMolecule | Peptide from protein | QPQSILIEH | 9 | null | 1,546 | 1,554 | 652961 | AAM48106.1 | null | Exact Epitope | null | TCell | 28536598 | 49 | Figure 4 | Positive | true | null | 10000000 | F | 6-8 weeks | null | 170 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Representative selection | null | 4 |
1048174.xml | 1048174 | 2026-04-03-07:00 | 41859109 | 2,026 | Immunoreactivity of pan MHC-I epitopes on Crimean-Congo hemorrhagic fever virus glycoprotein C-terminal. | Frontiers in immunology | Dongbo Jiang; Yongkai Wang; Haobo Kang; Zhenchi Fang; Jianchang Li; Zilu Ma; Yubo Sun; Yanbo Wang; Zhihe Fu; Yulin Yang; Enqi Guan; Yuanjie Sun; Shuya Yang; Chunmei Zhang; Yusi Zhang; Yun Zhang; Baozeng Sun; Kun Yang; Linfeng Cheng | 2454165 | QPQSILIEH | FragmentOfANaturalSequenceMolecule | Peptide from protein | QPQSILIEH | 9 | null | 1,546 | 1,554 | 652961 | AAM48106.1 | null | Exact Epitope | null | TCell | 28536599 | 49 | Figure 4 | Positive-Low | true | null | 10000649 | F | 6-8 weeks | null | 137 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Representative selection | null | 4 |
1048174.xml | 1048174 | 2026-04-03-07:00 | 41859109 | 2,026 | Immunoreactivity of pan MHC-I epitopes on Crimean-Congo hemorrhagic fever virus glycoprotein C-terminal. | Frontiers in immunology | Dongbo Jiang; Yongkai Wang; Haobo Kang; Zhenchi Fang; Jianchang Li; Zilu Ma; Yubo Sun; Yanbo Wang; Zhihe Fu; Yulin Yang; Enqi Guan; Yuanjie Sun; Shuya Yang; Chunmei Zhang; Yusi Zhang; Yun Zhang; Baozeng Sun; Kun Yang; Linfeng Cheng | 2454127 | ILIEHKGTI | FragmentOfANaturalSequenceMolecule | Peptide from protein | ILIEHKGTI | 9 | null | 1,550 | 1,558 | 652961 | AAM48106.1 | null | Exact Epitope | null | TCell | 28536600 | 49 | Figure 4 | Positive | true | null | 10000000 | F | 6-8 weeks | null | 170 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Representative selection | null | 8 |
1048174.xml | 1048174 | 2026-04-03-07:00 | 41859109 | 2,026 | Immunoreactivity of pan MHC-I epitopes on Crimean-Congo hemorrhagic fever virus glycoprotein C-terminal. | Frontiers in immunology | Dongbo Jiang; Yongkai Wang; Haobo Kang; Zhenchi Fang; Jianchang Li; Zilu Ma; Yubo Sun; Yanbo Wang; Zhihe Fu; Yulin Yang; Enqi Guan; Yuanjie Sun; Shuya Yang; Chunmei Zhang; Yusi Zhang; Yun Zhang; Baozeng Sun; Kun Yang; Linfeng Cheng | 2454127 | ILIEHKGTI | FragmentOfANaturalSequenceMolecule | Peptide from protein | ILIEHKGTI | 9 | null | 1,550 | 1,558 | 652961 | AAM48106.1 | null | Exact Epitope | null | TCell | 28536601 | 49 | Figure 4 | Positive-Low | true | null | 10000649 | F | 6-8 weeks | null | 137 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Representative selection | null | 8 |
1048174.xml | 1048174 | 2026-04-03-07:00 | 41859109 | 2,026 | Immunoreactivity of pan MHC-I epitopes on Crimean-Congo hemorrhagic fever virus glycoprotein C-terminal. | Frontiers in immunology | Dongbo Jiang; Yongkai Wang; Haobo Kang; Zhenchi Fang; Jianchang Li; Zilu Ma; Yubo Sun; Yanbo Wang; Zhihe Fu; Yulin Yang; Enqi Guan; Yuanjie Sun; Shuya Yang; Chunmei Zhang; Yusi Zhang; Yun Zhang; Baozeng Sun; Kun Yang; Linfeng Cheng | 2454148 | MLSGIFGNV | FragmentOfANaturalSequenceMolecule | Peptide from protein | MLSGIFGNV | 9 | null | 1,587 | 1,595 | 652961 | AAM48106.1 | null | Exact Epitope | null | TCell | 28536602 | 49 | Figure 4 | Positive-Low | true | null | 10000000 | F | 6-8 weeks | null | 170 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Representative selection | null | 6 |
1048174.xml | 1048174 | 2026-04-03-07:00 | 41859109 | 2,026 | Immunoreactivity of pan MHC-I epitopes on Crimean-Congo hemorrhagic fever virus glycoprotein C-terminal. | Frontiers in immunology | Dongbo Jiang; Yongkai Wang; Haobo Kang; Zhenchi Fang; Jianchang Li; Zilu Ma; Yubo Sun; Yanbo Wang; Zhihe Fu; Yulin Yang; Enqi Guan; Yuanjie Sun; Shuya Yang; Chunmei Zhang; Yusi Zhang; Yun Zhang; Baozeng Sun; Kun Yang; Linfeng Cheng | 2454148 | MLSGIFGNV | FragmentOfANaturalSequenceMolecule | Peptide from protein | MLSGIFGNV | 9 | null | 1,587 | 1,595 | 652961 | AAM48106.1 | null | Exact Epitope | null | TCell | 28536603 | 49 | Figure 4 | Positive | true | null | 10000649 | F | 6-8 weeks | null | 137 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Representative selection | null | 6 |
1048174.xml | 1048174 | 2026-04-03-07:00 | 41859109 | 2,026 | Immunoreactivity of pan MHC-I epitopes on Crimean-Congo hemorrhagic fever virus glycoprotein C-terminal. | Frontiers in immunology | Dongbo Jiang; Yongkai Wang; Haobo Kang; Zhenchi Fang; Jianchang Li; Zilu Ma; Yubo Sun; Yanbo Wang; Zhihe Fu; Yulin Yang; Enqi Guan; Yuanjie Sun; Shuya Yang; Chunmei Zhang; Yusi Zhang; Yun Zhang; Baozeng Sun; Kun Yang; Linfeng Cheng | 2454096 | APFILLILF | FragmentOfANaturalSequenceMolecule | Peptide from protein | APFILLILF | 9 | null | 1,604 | 1,612 | 652961 | AAM48106.1 | null | Exact Epitope | null | TCell | 28536604 | 49 | Figure 4 | Positive-High | true | null | 10000000 | F | 6-8 weeks | null | 170 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Representative selection | null | 3 |
1048174.xml | 1048174 | 2026-04-03-07:00 | 41859109 | 2,026 | Immunoreactivity of pan MHC-I epitopes on Crimean-Congo hemorrhagic fever virus glycoprotein C-terminal. | Frontiers in immunology | Dongbo Jiang; Yongkai Wang; Haobo Kang; Zhenchi Fang; Jianchang Li; Zilu Ma; Yubo Sun; Yanbo Wang; Zhihe Fu; Yulin Yang; Enqi Guan; Yuanjie Sun; Shuya Yang; Chunmei Zhang; Yusi Zhang; Yun Zhang; Baozeng Sun; Kun Yang; Linfeng Cheng | 2454096 | APFILLILF | FragmentOfANaturalSequenceMolecule | Peptide from protein | APFILLILF | 9 | null | 1,604 | 1,612 | 652961 | AAM48106.1 | null | Exact Epitope | null | TCell | 28536605 | 49 | Figure 4 | Positive-Low | true | null | 10000649 | F | 6-8 weeks | null | 137 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Representative selection | null | 3 |
1048174.xml | 1048174 | 2026-04-03-07:00 | 41859109 | 2,026 | Immunoreactivity of pan MHC-I epitopes on Crimean-Congo hemorrhagic fever virus glycoprotein C-terminal. | Frontiers in immunology | Dongbo Jiang; Yongkai Wang; Haobo Kang; Zhenchi Fang; Jianchang Li; Zilu Ma; Yubo Sun; Yanbo Wang; Zhihe Fu; Yulin Yang; Enqi Guan; Yuanjie Sun; Shuya Yang; Chunmei Zhang; Yusi Zhang; Yun Zhang; Baozeng Sun; Kun Yang; Linfeng Cheng | 2454175 | RRTRGLFKY | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRTRGLFKY | 9 | null | 1,627 | 1,635 | 652961 | AAM48106.1 | null | Exact Epitope | null | TCell | 28536606 | 49 | Figure 4 | Positive-Low | true | null | 10000000 | F | 6-8 weeks | null | 170 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Representative selection | null | 7 |
1048174.xml | 1048174 | 2026-04-03-07:00 | 41859109 | 2,026 | Immunoreactivity of pan MHC-I epitopes on Crimean-Congo hemorrhagic fever virus glycoprotein C-terminal. | Frontiers in immunology | Dongbo Jiang; Yongkai Wang; Haobo Kang; Zhenchi Fang; Jianchang Li; Zilu Ma; Yubo Sun; Yanbo Wang; Zhihe Fu; Yulin Yang; Enqi Guan; Yuanjie Sun; Shuya Yang; Chunmei Zhang; Yusi Zhang; Yun Zhang; Baozeng Sun; Kun Yang; Linfeng Cheng | 2454175 | RRTRGLFKY | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRTRGLFKY | 9 | null | 1,627 | 1,635 | 652961 | AAM48106.1 | null | Exact Epitope | null | TCell | 28536607 | 49 | Figure 4 | Positive-Low | true | null | 10000649 | F | 6-8 weeks | null | 137 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Representative selection | null | 7 |
1048175.xml | 1048175 | 2026-04-03-07:00 | 41818208 | 2,026 | Development and validation of a synthetic peptide-based field deployable latex slide agglutination test for detection of Tilapia tilapinevirus. | PloS one | Meshram Supradhnya Namdeo; Megha Kadam Bedekar; Jeena Kezhedath; Kooloth Valappil Rajendran; Anisha Valsalam; Ankita Godavarikar; Pooja Vinde; Sagar Hundare; Khangembam Victoria Chanu; Dimpal Thakuria; Narrotam P Sahu | 2454192 | TiLV segment 8 96-109_ KLH-CQ | FragmentOfANaturalSequenceMolecule | Peptide from protein | TNRKGQRFEFNRKQ | 14 | null | 96 | 109 | 1549864 | UQZ95899.1 | null | Epitope containing region/antigenic site | null | BCell | 28535027 | 168 | Figure 11, 12, 13, 14, Table 3 | Positive | true | null | 10000000 | null | 8 weeks | null | null | null | null | null | null | Representative selection | Exact match to reference information | null | 2 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 1330405 | Epitope of mAb CR3022 on SARS-CoV | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y356, N357, S362, T363, F364, K365, C366, Y367, G368, V369, S370, A371, T372, K373, D376, L377, R395, D415, M417 | null | null | 10002316 | ABF65836.1 | null | Exact Epitope | null | BCell | 28536419 | 589 | Figures 2, 5, and S2 | Positive | true | 7.31 | 9606 | null | null | DOID:2945 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 1330405 | Epitope of mAb CR3022 on SARS-CoV | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y356, N357, S362, T363, F364, K365, C366, Y367, G368, V369, S370, A371, T372, K373, D376, L377, R395, D415, M417 | null | null | 10002316 | ABF65836.1 | null | Exact Epitope | null | BCell | 28536420 | 586 | Figure S2 | Positive | true | 56100.0 | 9606 | null | null | DOID:2945 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 1330405 | Epitope of mAb CR3022 on SARS-CoV | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y356, N357, S362, T363, F364, K365, C366, Y367, G368, V369, S370, A371, T372, K373, D376, L377, R395, D415, M417 | null | null | 10002316 | ABF65836.1 | null | Exact Epitope | null | BCell | 28536422 | 589 | Figures 5 and S2 | Positive | true | 7.91 | 9606 | null | null | DOID:2945 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 1330405 | Epitope of mAb CR3022 on SARS-CoV | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y356, N357, S362, T363, F364, K365, C366, Y367, G368, V369, S370, A371, T372, K373, D376, L377, R395, D415, M417 | null | null | 10002316 | ABF65836.1 | null | Exact Epitope | null | BCell | 28536462 | 308 | Figure 4 | Positive | true | null | 10002278 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 1330405 | Epitope of mAb CR3022 on SARS-CoV | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y356, N357, S362, T363, F364, K365, C366, Y367, G368, V369, S370, A371, T372, K373, D376, L377, R395, D415, M417 | null | null | 10002316 | ABF65836.1 | null | Exact Epitope | null | BCell | 28536423 | 586 | Figure S2 | Positive | true | 78700.0 | 9606 | null | null | DOID:2945 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 1330405 | Epitope of mAb CR3022 on SARS-CoV | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y356, N357, S362, T363, F364, K365, C366, Y367, G368, V369, S370, A371, T372, K373, D376, L377, R395, D415, M417 | null | null | 10002316 | ABF65836.1 | null | Exact Epitope | null | BCell | 28536424 | 316 | Figures 5 and S2 | Positive | true | null | 9606 | null | null | DOID:2945 | null | null | null | null | null | Representative selection | Representative selection | null | 9 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 1330405 | Epitope of mAb CR3022 on SARS-CoV | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y356, N357, S362, T363, F364, K365, C366, Y367, G368, V369, S370, A371, T372, K373, D376, L377, R395, D415, M417 | null | null | 10002316 | ABF65836.1 | null | Exact Epitope | null | BCell | 28536427 | 308 | Figure 2 | Positive | true | null | 10002278 | null | null | null | null | null | null | null | null | Exact match to reference information | null | null | 9 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 1330405 | Epitope of mAb CR3022 on SARS-CoV | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y356, N357, S362, T363, F364, K365, C366, Y367, G368, V369, S370, A371, T372, K373, D376, L377, R395, D415, M417 | null | null | 10002316 | ABF65836.1 | null | Exact Epitope | null | BCell | 28536428 | 308 | Figures 2 and 3 | Positive | true | null | 10002278 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 1330405 | Epitope of mAb CR3022 on SARS-CoV | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y356, N357, S362, T363, F364, K365, C366, Y367, G368, V369, S370, A371, T372, K373, D376, L377, R395, D415, M417 | null | null | 10002316 | ABF65836.1 | null | Exact Epitope | null | BCell | 28536430 | 308 | Figure 2 | Positive-Low | true | null | 10000067 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 1330405 | Epitope of mAb CR3022 on SARS-CoV | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y356, N357, S362, T363, F364, K365, C366, Y367, G368, V369, S370, A371, T372, K373, D376, L377, R395, D415, M417 | null | null | 10002316 | ABF65836.1 | null | Exact Epitope | null | BCell | 28536431 | 308 | Figure 2 | Positive | true | null | 10002278 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 1330405 | Epitope of mAb CR3022 on SARS-CoV | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y356, N357, S362, T363, F364, K365, C366, Y367, G368, V369, S370, A371, T372, K373, D376, L377, R395, D415, M417 | null | null | 10002316 | ABF65836.1 | null | Exact Epitope | null | BCell | 28536465 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | DOID:2945 | null | null | null | null | null | Representative selection | Representative selection | null | 9 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 1330405 | Epitope of mAb CR3022 on SARS-CoV | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y356, N357, S362, T363, F364, K365, C366, Y367, G368, V369, S370, A371, T372, K373, D376, L377, R395, D415, M417 | null | null | 10002316 | ABF65836.1 | null | Exact Epitope | null | BCell | 28536469 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | DOID:2945 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 1330405 | Epitope of mAb CR3022 on SARS-CoV | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y356, N357, S362, T363, F364, K365, C366, Y367, G368, V369, S370, A371, T372, K373, D376, L377, R395, D415, M417 | null | null | 10002316 | ABF65836.1 | null | Exact Epitope | null | BCell | 28536466 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | DOID:2945 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 1330405 | Epitope of mAb CR3022 on SARS-CoV | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y356, N357, S362, T363, F364, K365, C366, Y367, G368, V369, S370, A371, T372, K373, D376, L377, R395, D415, M417 | null | null | 10002316 | ABF65836.1 | null | Exact Epitope | null | BCell | 28536467 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | DOID:2945 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 1330405 | Epitope of mAb CR3022 on SARS-CoV | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y356, N357, S362, T363, F364, K365, C366, Y367, G368, V369, S370, A371, T372, K373, D376, L377, R395, D415, M417 | null | null | 10002316 | ABF65836.1 | null | Exact Epitope | null | BCell | 28536468 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | DOID:2945 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 1330405 | Epitope of mAb CR3022 on SARS-CoV | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y356, N357, S362, T363, F364, K365, C366, Y367, G368, V369, S370, A371, T372, K373, D376, L377, R395, D415, M417 | null | null | 10002316 | ABF65836.1 | null | Exact Epitope | null | BCell | 28536470 | 34 | Figure 5 | Positive-Low | true | null | 9606 | null | null | DOID:2945 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 1330405 | Epitope of mAb CR3022 on SARS-CoV | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y356, N357, S362, T363, F364, K365, C366, Y367, G368, V369, S370, A371, T372, K373, D376, L377, R395, D415, M417 | null | null | 10002316 | ABF65836.1 | null | Exact Epitope | null | BCell | 28536472 | 34 | Figure 5 | Positive-Low | true | null | 9606 | null | null | DOID:2945 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 1330405 | Epitope of mAb CR3022 on SARS-CoV | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y356, N357, S362, T363, F364, K365, C366, Y367, G368, V369, S370, A371, T372, K373, D376, L377, R395, D415, M417 | null | null | 10002316 | ABF65836.1 | null | Exact Epitope | null | BCell | 28536471 | 34 | Figure 5 | Positive-Low | true | null | 9606 | null | null | DOID:2945 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454284 | Epitope of Fab BoWLB-105 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536473 | 436 | Figure 6, Tables 1 and S4, and PDB 9PSN | Positive | true | 2.54 | 10002278 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 3 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454284 | Epitope of Fab BoWLB-105 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536477 | 34 | Figure 5 | Positive | true | null | 10002278 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 3 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454284 | Epitope of Fab BoWLB-105 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536476 | 589 | Figure 5 | Positive | true | 5.0 | 10002278 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 3 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454284 | Epitope of Fab BoWLB-105 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536478 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 3 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454284 | Epitope of Fab BoWLB-105 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536479 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 3 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454284 | Epitope of Fab BoWLB-105 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536480 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 3 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454284 | Epitope of Fab BoWLB-105 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536484 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 3 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454284 | Epitope of Fab BoWLB-105 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536481 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 3 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454284 | Epitope of Fab BoWLB-105 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536482 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 3 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454284 | Epitope of Fab BoWLB-105 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536483 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 3 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454284 | Epitope of Fab BoWLB-105 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536491 | 316 | Figure 5 | Positive-High | true | null | 10002278 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 3 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454284 | Epitope of Fab BoWLB-105 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536485 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 3 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454284 | Epitope of Fab BoWLB-105 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536486 | 34 | Figure 5 | Positive-Low | true | null | 9606 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 3 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454284 | Epitope of Fab BoWLB-105 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536488 | 316 | Figure 5 | Positive | true | null | 10002278 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 3 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454284 | Epitope of Fab BoWLB-105 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536490 | 316 | Figure 5 | Positive | true | null | 10002278 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 3 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454286 | Epitope of Fab BoWLB-622 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536507 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454286 | Epitope of Fab BoWLB-622 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536508 | 316 | Figure 5 | Positive | true | null | 10002278 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454286 | Epitope of Fab BoWLB-622 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536509 | 316 | Figure 5 | Positive | true | null | 10002278 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454286 | Epitope of Fab BoWLB-622 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536510 | 316 | Figure 5 | Positive | true | null | 10002278 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454286 | Epitope of Fab BoWLB-622 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536496 | 436 | Figure 6, Tables 1 and S4, and PDB 9PSO | Positive | true | 2.62 | 10002278 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454286 | Epitope of Fab BoWLB-622 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536497 | 589 | Figure 5 | Positive | true | 5.0 | 10002278 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454286 | Epitope of Fab BoWLB-622 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536498 | 34 | Figure 5 | Positive | true | null | 10002278 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454286 | Epitope of Fab BoWLB-622 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536501 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454286 | Epitope of Fab BoWLB-622 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536499 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454286 | Epitope of Fab BoWLB-622 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536500 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454286 | Epitope of Fab BoWLB-622 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536503 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454286 | Epitope of Fab BoWLB-622 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536504 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454286 | Epitope of Fab BoWLB-622 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536531 | 316 | Figure 5 | Positive-Low | true | null | 10002278 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454286 | Epitope of Fab BoWLB-622 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536532 | 316 | Figure 5 | Positive-High | true | null | 10002278 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454286 | Epitope of Fab BoWLB-622 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536533 | 316 | Figure 5 | Positive-Low | true | null | 10002278 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454286 | Epitope of Fab BoWLB-622 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536530 | 316 | Figure 5 | Positive-Low | true | null | 10002278 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 5 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454286 | Epitope of Fab BoWLB-622 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536502 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454286 | Epitope of Fab BoWLB-622 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536505 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454286 | Epitope of Fab BoWLB-622 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | null | null | 10002370 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, T430, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536506 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 5 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454285 | Epitope of Fab BoWLB-1173 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 2697049 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536511 | 436 | Figure 6, Tables 1 and S4, and PDB 9PSP | Positive | true | 2.81 | 10002278 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 8 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454285 | Epitope of Fab BoWLB-1173 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 2697049 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536512 | 589 | Figure 5 | Positive | true | 5.0 | 10002278 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 8 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454285 | Epitope of Fab BoWLB-1173 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 2697049 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536513 | 34 | Figure 5 | Positive | true | null | 10002278 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 8 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454285 | Epitope of Fab BoWLB-1173 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 2697049 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536514 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454285 | Epitope of Fab BoWLB-1173 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 2697049 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536515 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 8 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454285 | Epitope of Fab BoWLB-1173 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 2697049 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536516 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 8 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454285 | Epitope of Fab BoWLB-1173 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 2697049 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536520 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 8 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454285 | Epitope of Fab BoWLB-1173 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 2697049 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536521 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 8 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454285 | Epitope of Fab BoWLB-1173 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 2697049 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536517 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 8 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454285 | Epitope of Fab BoWLB-1173 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 2697049 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536518 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 8 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454285 | Epitope of Fab BoWLB-1173 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 2697049 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536519 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 8 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454285 | Epitope of Fab BoWLB-1173 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 2697049 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536522 | 34 | Figure 5 | Positive | true | null | 9606 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454285 | Epitope of Fab BoWLB-1173 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 2697049 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536523 | 316 | Figure 5 | Positive | true | null | 10002278 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454285 | Epitope of Fab BoWLB-1173 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 2697049 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536524 | 316 | Figure 5 | Positive | true | null | 10002278 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454285 | Epitope of Fab BoWLB-1173 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 2697049 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536525 | 316 | Figure 5 | Positive-High | true | null | 10002278 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454285 | Epitope of Fab BoWLB-1173 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 2697049 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536534 | 316 | Figure 5 | Positive-Low | true | null | 10002278 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454285 | Epitope of Fab BoWLB-1173 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 2697049 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536535 | 316 | Figure 5 | Positive-Intermediate | true | null | 10002278 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454285 | Epitope of Fab BoWLB-1173 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | null | null | 2697049 | P0DTC2.1 | Y369, N370, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, D428, T430, F515, E516, L517, L518, H519 | Exact Epitope | null | BCell | 28536536 | 316 | Figure 5 | Positive-Intermediate | true | null | 10002278 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454283 | Epitope of Fab CC12.3 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | R403, T415, G416, K417, D420, Y421, Y453, L455, F456, R457, K458, N460, Y473, A475, G476, F486, N487, Y489, Y495, Q498, N501, Y505 | null | null | 2697049 | P0DTC2.1 | R403, T415, G416, K417, D420, Y421, Y453, L455, F456, R457, K458, N460, Y473, A475, G476, F486, N487, Y489, Y495, Q498, N501, Y505 | Exact Epitope | null | BCell | 28536417 | 436 | Table S4 and PDB 9PSO | Positive | true | 2.62 | 9606 | null | null | DOID:0080600 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454283 | Epitope of Fab CC12.3 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | R403, T415, G416, K417, D420, Y421, Y453, L455, F456, R457, K458, N460, Y473, A475, G476, F486, N487, Y489, Y495, Q498, N501, Y505 | null | null | 2697049 | P0DTC2.1 | R403, T415, G416, K417, D420, Y421, Y453, L455, F456, R457, K458, N460, Y473, A475, G476, F486, N487, Y489, Y495, Q498, N501, Y505 | Exact Epitope | null | BCell | 28536418 | 436 | Table S4 and PDB 9PSP | Positive | true | 2.81 | 9606 | null | null | DOID:0080600 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048176.xml | 1048176 | 2026-04-08-07:00 | 41865371 | 2,026 | In vivo evolution of antibody CR3022 expands cross-neutralization of SARS-CoV-2 variants and informs pan-sarbecovirus immunity. | Cell reports | Yanbin Fu; Ziqi Feng; Steven A Erickson; Peter J Halfmann; Lei Li; Jordan C Chervin; Chloe A Troxell; Jiayi Sun; Atsuhiro Yasuhara; Siriruk Changrob; Min Huang; Nai-Ying Zheng; Meng Yuan; Yoshihiro Kawaoka; Ian A Wilson; Patrick C Wilson | 2454283 | Epitope of Fab CC12.3 on SARS-CoV2 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | R403, T415, G416, K417, D420, Y421, Y453, L455, F456, R457, K458, N460, Y473, A475, G476, F486, N487, Y489, Y495, Q498, N501, Y505 | null | null | 2697049 | P0DTC2.1 | R403, T415, G416, K417, D420, Y421, Y453, L455, F456, R457, K458, N460, Y473, A475, G476, F486, N487, Y489, Y495, Q498, N501, Y505 | Exact Epitope | null | BCell | 28536416 | 436 | Table S4 and PDB 9PSN | Positive | true | 2.54 | 9606 | null | null | DOID:0080600 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 4 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454212 | Epitope of Fab COV2-3835 on Omicron BA.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | T342, R343, F344, A345, S346, Y348, A349, L438, D439, S440, K441, S443, N445, Y446, N447, Y448, L449, R463, I465, F487, L489 | null | null | 10002679 | UJU86738.1 | T342, R343, F344, A345, S346, Y348, A349, L438, D439, S440, K441, S443, N445, Y446, N447, Y448, L449, R463, I465, F487, L489 | Partial Epitope | null | BCell | 28536145 | 437 | Figure 4, Extended Data Figure 6, Supplementary Table 4, and PDB 9NVG | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 4 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454214 | Epitope of Fab COV2-3891 on Omicron BQ.1.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N434, K435, V440, R493, P494, T495, Y496, G497, V498, Q501 | null | null | 10002869 | WCI16184.1 | N439, K440, V445, R498, P499, T500, Y501, G502, V503, Q506 | Partial Epitope | null | BCell | 28536155 | 34 | Figures 2 and 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 8 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454214 | Epitope of Fab COV2-3891 on Omicron BQ.1.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N434, K435, V440, R493, P494, T495, Y496, G497, V498, Q501 | null | null | 10002869 | WCI16184.1 | N439, K440, V445, R498, P499, T500, Y501, G502, V503, Q506 | Partial Epitope | null | BCell | 28536156 | 34 | Figure 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454214 | Epitope of Fab COV2-3891 on Omicron BQ.1.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N434, K435, V440, R493, P494, T495, Y496, G497, V498, Q501 | null | null | 10002869 | WCI16184.1 | N439, K440, V445, R498, P499, T500, Y501, G502, V503, Q506 | Partial Epitope | null | BCell | 28536157 | 34 | Figure 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454214 | Epitope of Fab COV2-3891 on Omicron BQ.1.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N434, K435, V440, R493, P494, T495, Y496, G497, V498, Q501 | null | null | 10002869 | WCI16184.1 | N439, K440, V445, R498, P499, T500, Y501, G502, V503, Q506 | Partial Epitope | null | BCell | 28536146 | 437 | Figure 4, Extended Data Figure 7, Supplementary Table 5, and PDB 9C7S | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454214 | Epitope of Fab COV2-3891 on Omicron BQ.1.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N434, K435, V440, R493, P494, T495, Y496, G497, V498, Q501 | null | null | 10002869 | WCI16184.1 | N439, K440, V445, R498, P499, T500, Y501, G502, V503, Q506 | Partial Epitope | null | BCell | 28536152 | 34 | Figures 2 and 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 8 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454214 | Epitope of Fab COV2-3891 on Omicron BQ.1.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N434, K435, V440, R493, P494, T495, Y496, G497, V498, Q501 | null | null | 10002869 | WCI16184.1 | N439, K440, V445, R498, P499, T500, Y501, G502, V503, Q506 | Partial Epitope | null | BCell | 28536153 | 34 | Figure 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 8 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454214 | Epitope of Fab COV2-3891 on Omicron BQ.1.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N434, K435, V440, R493, P494, T495, Y496, G497, V498, Q501 | null | null | 10002869 | WCI16184.1 | N439, K440, V445, R498, P499, T500, Y501, G502, V503, Q506 | Partial Epitope | null | BCell | 28536161 | 316 | Figure 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454214 | Epitope of Fab COV2-3891 on Omicron BQ.1.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N434, K435, V440, R493, P494, T495, Y496, G497, V498, Q501 | null | null | 10002869 | WCI16184.1 | N439, K440, V445, R498, P499, T500, Y501, G502, V503, Q506 | Partial Epitope | null | BCell | 28536154 | 34 | Figure 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 8 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454214 | Epitope of Fab COV2-3891 on Omicron BQ.1.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N434, K435, V440, R493, P494, T495, Y496, G497, V498, Q501 | null | null | 10002869 | WCI16184.1 | N439, K440, V445, R498, P499, T500, Y501, G502, V503, Q506 | Partial Epitope | null | BCell | 28536159 | 34 | Figure 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454214 | Epitope of Fab COV2-3891 on Omicron BQ.1.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N434, K435, V440, R493, P494, T495, Y496, G497, V498, Q501 | null | null | 10002869 | WCI16184.1 | N439, K440, V445, R498, P499, T500, Y501, G502, V503, Q506 | Partial Epitope | null | BCell | 28536160 | 316 | Figure 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454214 | Epitope of Fab COV2-3891 on Omicron BQ.1.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N434, K435, V440, R493, P494, T495, Y496, G497, V498, Q501 | null | null | 10002869 | WCI16184.1 | N439, K440, V445, R498, P499, T500, Y501, G502, V503, Q506 | Partial Epitope | null | BCell | 28536165 | 316 | Figure 3, Extended Data Figure 3, and Extended Data Table 1 | Positive-Intermediate | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454214 | Epitope of Fab COV2-3891 on Omicron BQ.1.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N434, K435, V440, R493, P494, T495, Y496, G497, V498, Q501 | null | null | 10002869 | WCI16184.1 | N439, K440, V445, R498, P499, T500, Y501, G502, V503, Q506 | Partial Epitope | null | BCell | 28536162 | 316 | Figure 3 | Positive-Intermediate | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454214 | Epitope of Fab COV2-3891 on Omicron BQ.1.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N434, K435, V440, R493, P494, T495, Y496, G497, V498, Q501 | null | null | 10002869 | WCI16184.1 | N439, K440, V445, R498, P499, T500, Y501, G502, V503, Q506 | Partial Epitope | null | BCell | 28536163 | 316 | Figure 3 | Positive-Intermediate | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454214 | Epitope of Fab COV2-3891 on Omicron BQ.1.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N434, K435, V440, R493, P494, T495, Y496, G497, V498, Q501 | null | null | 10002869 | WCI16184.1 | N439, K440, V445, R498, P499, T500, Y501, G502, V503, Q506 | Partial Epitope | null | BCell | 28536164 | 316 | Figure 3, Extended Data Figure 3, and Extended Data Table 1 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.